<?xml version="1.0" encoding="UTF-8"?>
<p>Radiological imaging is extremely useful in assessing the degree of lung damage and lung parenchyma involvement and sometimes replaces laboratory tests in diagnostics. The presented images are varied, and their progression is fast [
 <xref rid="B19-jcm-09-01917" ref-type="bibr">19</xref>,
 <xref rid="B20-jcm-09-01917" ref-type="bibr">20</xref>,
 <xref rid="B21-jcm-09-01917" ref-type="bibr">21</xref>,
 <xref rid="B22-jcm-09-01917" ref-type="bibr">22</xref>]. In one of the studies, the computed tomography (CT) images of 63 patients with COVID-19 were analyzed [
 <xref rid="B21-jcm-09-01917" ref-type="bibr">21</xref>]. The average number of affected pulmonary lobes was 3.3 Â± 1.8, the most common changes were patchy ground-glass opacities, 17.5% patients had fibrous stripes and 12.7% patients had irregular solid nodules [
 <xref rid="B23-jcm-09-01917" ref-type="bibr">23</xref>]. The vast majority of patients (85%) progressed, while the nodules and stripes enlarged [
 <xref rid="B19-jcm-09-01917" ref-type="bibr">19</xref>,
 <xref rid="B21-jcm-09-01917" ref-type="bibr">21</xref>,
 <xref rid="B22-jcm-09-01917" ref-type="bibr">22</xref>]. Pulmonary fibrosis may be one of the major complications in COVID-19 patients [
 <xref rid="B19-jcm-09-01917" ref-type="bibr">19</xref>].
</p>
